Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Oral Drug Delivery Systems: Introduction

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.

Drug Delivery Systems: Different Types

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...

Modified-Release Drug Delivery Systems: Overview

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance.

ACS nano·2026

Same author

Artificial intelligence in antimicrobial drug discovery: predictive and generative strategies.

Expert opinion on drug discovery·2026

Same author

A ferroptosis-based intelligent nanoplatform with chemo-sonodynamic therapy carrying oxygen for improving tumor suppression and antitumor immunity.

Journal of nanobiotechnology·2026

Same author

A farnesol-sensing triad in <i>Pseudomonas aeruginosa</i> drives interkingdom predation on <i>Candida albicans</i> via signal transduction.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

A sequential dual-drug delivery system for multi-target inhibition of subretinal fibrosis.

Journal of nanobiotechnology·2026

Same author

Structural mechanism of 3'3'-cGAMP-induced filamentation and phospholipid hydrolysis by CapV in bacterial antiphage defense.

Cell reports·2026

Search research articles

Related Experiment Video

Updated: May 20, 2026

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Published on: December 22, 2023

Advances in nanotechnology-based delivery systems for curcumin.

Min Sun¹, Xun Su, Buyun Ding

¹Department of Pharmaceutics, School of Pharmaceutical Sciences, Shandong University, Jinan, China.

Nanomedicine (London, England)

|August 1, 2012

Summary

Curcumin (CUR), a turmeric component, shows therapeutic potential but suffers from poor bioavailability. Nanotechnology delivery systems offer promising solutions to enhance CUR

More Related Videos

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Related Experiment Videos

Last Updated: May 20, 2026

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Published on: December 22, 2023

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Area of Science:

Pharmacology and Drug Delivery
Natural Product Chemistry
Nanotechnology Applications

Background:

Curcumin (CUR), derived from Curcuma longa, possesses significant pharmacological potential for various diseases.
Clinical use of CUR is hindered by poor stability, low solubility, and rapid metabolism, limiting its bioavailability.
Nanotechnology offers innovative strategies to overcome CUR's delivery challenges.

Purpose of the Study:

To review novel nanotechnology-based drug delivery systems for Curcumin (CUR).
To explore how these systems enhance CUR's oral bioavailability, biological activity, and tissue targeting.
To highlight the potential of advanced delivery platforms for improving CUR's therapeutic efficacy.

Main Methods:

Literature review of nanotechnology-based delivery systems for CUR.
Analysis of various nanocarriers including liposomes, nanoparticles, micelles, and nanoemulsions.
Evaluation of studies demonstrating improved CUR bioavailability and activity via these systems.

Main Results:

Numerous nanotechnology platforms show promise in enhancing CUR's properties.
Liposomes, polymeric nanoparticles, solid lipid nanoparticles, micelles, nanogels, nanosuspensions, nanoemulsions, complexes, and dendrimers are effective carriers.
These systems significantly improve oral bioavailability, biological activity, and targeting of CUR.

Conclusions:

Nanotechnology-based delivery systems are crucial for overcoming CUR's limitations.
Advanced delivery platforms offer a promising future for the clinical application of curcumin.
Further research into these novel systems can unlock the full therapeutic potential of CUR.